ENANTA PHARMACEUTICALS INC - 10-Q Filing
Enanta Pharmaceuticals filed its quarterly report for the period ended March 31, 2026. The filing includes financial data and disclosures related to research and development expenses, general and administrative expenses, stock-based compensation programs including performance shares and restricted stock units (RSUs), and details on marketable securities such as U.S. Treasury securities.
Tickers: $ENTA